Pharmacoepidemiology and Benefit-Risk Management

Risk minimisation – design, implementation & evaluation

Our experts have been developing and implementing additional risk minimisation measures (aRMMs) for products from various disease areas according to the requirements of the EU PV legislation, as part of REMSs, and for global risk minimisation approaches.

We have successfully developed and implemented electronic risk minimisation tools, such as educational websites or Smartphone Apps, including the adaptation to the specific requirements of different EU and non-EU countries. Furthermore, we have helped companies in the development and implementation of processes for the systematic planning and execution of aRMMs globally. We have also designed and implemented measures and studies for the evaluation of risk minimisation tool effectiveness.

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services